is it safe to switch from semaglutide to tirzepatide Can I Tirzepatide? Can I switch from tirzepatide

Recent studies have shown an increasing number of cases involving gastrointestinal problems linked to the use of glucagon-like peptide-1 (GLP-1) receptor agonists

Semaglutide Injection Site Bruising Bruising at the injection site, while not very common, can occur with semaglutide injections

Additional testing may help provide a diagnosis

Additional thermogenic ingredients L-carnitine and L-lysine help boost metabolism

The mechanism behind this is synergistic rather than additive

Key Safety Differentiators No IGF-1 elevation: AOD-9604 does not stimulate IGF-1, meaning it avoids risks such as organ/tissue overgrowth or acromegaly No glucose disruption: Clinical data shows it does not impair insulin sensitivity or worsen blood sugar regulation Comparable to placebo: In obesity trials, the incidence of adverse effects was similar to placebo groups, underscoring its tolerability Legal Status of AOD-9604 United States: AOD-9604 is not FDA-approved as a drug, dietary supplement, or weight loss therapy